Summary
Asston Pharmaceuticals share holding pattern reports the following shareholding: Asston Pharmaceuticals Total Promoters is at 50.66%, Mutual Fund at 0.00%, Insurance at 0.00%, Foreign Institutional Investors at 1.91%, Domestic Institutional Investors at 0.00%, and Retail at 47.42%. This breakdown provides a quick snapshot of ownership distribution for Asston Pharmaceuticals share holding pattern in 2026-27.
Asston Pharmaceuticals FAQs
As of 05-2026, the promoter shareholding in Asston Pharmaceuticals stands at 50.66% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Asston Pharmaceuticals is 1.91% and 0% respectively.
The retail shareholding of the Asston Pharmaceuticals is 47.42%.
Changes in shareholding patterns of Asston Pharmaceuticals can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Asston Pharmaceuticals are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
Asston Pharmaceuticals Associated Pages
